191 related articles for article (PubMed ID: 9028934)
21. [In vitro cytokines-induced differentiation in mononuclear cell derived dendritic cells from chronic myeloid leukemia].
Zhang YF; Wu CY; Zhang LS; Chai Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):137-41. PubMed ID: 16584610
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia.
Harrison BD; Adams JA; Briggs M; Brereton ML; Yin JA
Blood; 2001 May; 97(9):2764-71. PubMed ID: 11313269
[TBL] [Abstract][Full Text] [Related]
23. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
[TBL] [Abstract][Full Text] [Related]
24. The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia.
van der Hoorn MA; van Luxemburg-Heijs SA; van Bergen CA; Bongaerts R; Willemze R; Falkenburg JH
Methods; 2003 Oct; 31(2):113-9. PubMed ID: 12957568
[TBL] [Abstract][Full Text] [Related]
25. [Effect of PD-L1 blockade on function of dendritic cells derived from chronic myelocytic leukemia].
Wang CY; Zhang LS; Tian FQ; Huang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1146-9. PubMed ID: 18928614
[TBL] [Abstract][Full Text] [Related]
26. In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC.
Nourizadeh M; Masoumi F; Memarian A; Alimoghaddam K; Moazzeni SM; Yaghmaie M; Hadjati J
Target Oncol; 2014 Sep; 9(3):225-37. PubMed ID: 23852664
[TBL] [Abstract][Full Text] [Related]
27. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
[TBL] [Abstract][Full Text] [Related]
28. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses.
Weigel BJ; Nath N; Taylor PA; Panoskaltsis-Mortari A; Chen W; Krieg AM; Brasel K; Blazar BR
Blood; 2002 Dec; 100(12):4169-76. PubMed ID: 12393694
[TBL] [Abstract][Full Text] [Related]
30. [Influence of cryopreservation on leukemic dendritic cells derived from leukemia patients].
Huang YZ; Shen JL; Wang LX; Xiang D; Zheng PH; Cen J; Gong LZ; Liu Y; Yang PD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):873-7. PubMed ID: 17708823
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
[TBL] [Abstract][Full Text] [Related]
32. [Specific anti-leukemic cell effect mediated by dendritic cells pulsed with chronic myelogenous leukemia lysate antigen in vitro].
Zhu HH; Xu KL; Pan XY; Liu JQ; Chen FX; Huang YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):278-81. PubMed ID: 12844413
[TBL] [Abstract][Full Text] [Related]
33. [Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen].
He B; Qiu G; Xie X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):974-8. PubMed ID: 15646345
[TBL] [Abstract][Full Text] [Related]
34. Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures.
Müller L; Provenzani C; Pawelec G
J Immunother; 2001; 24(6):482-92. PubMed ID: 11759071
[TBL] [Abstract][Full Text] [Related]
35. Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells.
Mumprecht S; Claus C; Schürch C; Pavelic V; Matter MS; Ochsenbein AF
Blood; 2009 May; 113(19):4681-9. PubMed ID: 19252140
[TBL] [Abstract][Full Text] [Related]
36. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes.
Falkenburg JH; Wafelman AR; Joosten P; Smit WM; van Bergen CA; Bongaerts R; Lurvink E; van der Hoorn M; Kluck P; Landegent JE; Kluin-Nelemans HC; Fibbe WE; Willemze R
Blood; 1999 Aug; 94(4):1201-8. PubMed ID: 10438707
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features.
Eisendle K; Wolf D; Gastl G; Kircher-Eibl B
Leuk Lymphoma; 2005 May; 46(5):663-70. PubMed ID: 16019503
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia.
Nieda M; Nicol A; Kikuchi A; Kashiwase K; Taylor K; Suzuki K; Tadokoro K; Juji T
Blood; 1998 Feb; 91(3):977-83. PubMed ID: 9446659
[TBL] [Abstract][Full Text] [Related]
39. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
Zheng SE; Jin J; Tong XM; Qian WB; Xue YQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):920-3. PubMed ID: 17533744
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration.
Dong R; Cwynarski K; Entwistle A; Marelli-Berg F; Dazzi F; Simpson E; Goldman JM; Melo JV; Lechler RI; Bellantuono I; Ridley A; Lombardi G
Blood; 2003 May; 101(9):3560-7. PubMed ID: 12506035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
